Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02697227 · ClinicalTrials.gov registry record · NA

Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation

A NA study of Tobacco Use Disorder and Cigarette Smoker, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT02697227 is a NA study of Tobacco Use Disorder and Cigarette Smoker that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 85 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02697227, a NA study of Tobacco Use Disorder and Cigarette Smoker, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial studies how well behavioral activation therapy and nicotine replacement therapy work in increasing smoking cessation. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Giving behavioral activation therapy and nicotine replacement therapy may help patients quit smoking or change their smoking behavior.

Conditions Studied

Tobacco Use Disorder Cigarette Smoker

Interventions

  • OTHER Laboratory Biomarker Analysis
  • BEHAVIORAL Smoking Cessation Intervention
  • OTHER Questionnaire Administration
  • BEHAVIORAL Behavioral Intervention
  • DRUG Nicotine Patch

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2016-08-05
Est. Completion 2027-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02697227

The ClinicalTrials.gov registry entry for NCT02697227 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (64% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT02697227 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02697227 about?

NCT02697227 is a clinical study titled "Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation". This randomized clinical trial studies how well behavioral activation therapy and nicotine replacement therapy work in increasing smoking cessation. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Giving...

What is the current status of trial NCT02697227?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2016-08-05. Estimated completion is 2027-12-31.

What conditions does trial NCT02697227 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Cigarette Smoker.

What interventions are being tested in trial NCT02697227?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Smoking Cessation Intervention (BEHAVIORAL), Questionnaire Administration (OTHER), Behavioral Intervention (BEHAVIORAL), Nicotine Patch (DRUG).

Who is sponsoring clinical trial NCT02697227?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02697227 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use Disorder

All registered trials for this condition

Cigarette Smoker

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.